N.M. Admin. Code § 16.19.36.8 - PHARMACIST IN CHARGE
A. All
facilities compounding sterile preparations must designate a pharmacist in
charge of operations who is licensed as a pharmacist in the state of residence
of the facility.
B. The
pharmacist-in-charge (or consultant pharmacist, for in-state clinics) is
responsible for:
(1) the development,
implementation and continuing review and maintenance of written policies,
procedures and SOP's which comply with USP/NF standards;
(2) providing a pharmacist who is available
for 24 hour seven-day-a-week services;
(3) establishing a system to ensure that the
CSP's prepared by compounding personnel are administered by licensed personnel
or properly trained and instructed patients;
(4) establishing a system to ensure that
CSP's prepared by compounding personnel are prepared in compliance with USP/NF
<797> (USP General Chapters: <797> Pharmaceutical
Compounding-Sterile Preparations) standards;
(5) ensuring facility personnel comply with
written policies, procedures, and SOP's; and
(6) developing an appropriate and
individualized plan of care in collaboration with patient or caregiver and
other healthcare providers for each patient receiving parenteral preparations
in a home setting.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.